Literature DB >> 12325038

High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.

Yu-Jing Zhang1, Habibul Ahsan, Yu Chen, Ruth M Lunn, Li-Yu Wang, Shu-Yuan Chen, Po-Huang Lee, Chien-Jen Chen, Regina M Santella.   

Abstract

Epigenetic changes in gene expression due to extensive CpG island methylation is now accepted as the main cause of inactivation of the p16 gene. More recently, it has been suggested that the human ras association domain family (RASSF) 1 gene, cloned from the lung tumor-suppressor locus 3p21.3, also may be inactivated by methylation. It consists of two major alternative transcripts, RASSF1A and RASSF1C. Epigenetic inactivation of isoform A was observed in several carcinomas and tumor cell lines. In this study, promoter hypermethylation of RASSF1A and p16 was investigated in 83 hepatocellular carcinoma (HCC) tissue samples from Taiwan and in two HCC cell lines (Hep3B and HepG2). High frequencies (85% and 47%, respectively) of methylation of the CpG island promoters of RASSF1A and p16 were found in the HCC tissues. The methylation of RASSF1A also was detected in Hep3B cells but not in HepG2 cells; p16 was not methylated in either cell line. Methylation status was determined in 12 normal control liver tissues and 10 adjacent nontumor tissues. No methylation was found in normal liver control tissues for both RASSF1A and p16; methylation was detected in one of 10 and seven of 10 adjacent nontumor tissue sampless for p16 and RASSF1A, respectively, in subjects with positive tumors. These data indicate that aberrant methylation of the CpG island promoters of both genes is a frequent occurrence in hepatocarcinogenesis. The high frequency of RASSF1A methylation in adjacent tissues suggests that this may be an early event. The relationship between methylation status and clinical parameters and tumor markers, including DNA damage resulting from aflatoxin B(1) (AFB(1)), an environmental carcinogen, and p53 status, also was analyzed. A statistically significant association was found between RASSF1A methylation status and the level of AFB(1)-DNA adducts in tumor tissues. No association was found between methylation status and p53 status. These results suggest the hypothesis that exposure to environmental carcinogens may be involved in altered methylation of genes involved in cancer development. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325038     DOI: 10.1002/mc.10076

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  38 in total

1.  Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.

Authors:  Yu-Jing Zhang; Hui-Chen Wu; Hulya Yazici; Ming-Whei Yu; Po-Huang Lee; Regina M Santella
Journal:  World J Hepatol       Date:  2012-05-27

Review 2.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

3.  Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma.

Authors:  Hong Tang; Lingxi Jiang; Cailei Zhu; Raymond Liu; Yufeng Wu; Qian Yan; Ming Liu; Yongxu Jia; Juan Chen; Yanru Qin; Victor Ho-Fun Lee; Suxia Luo; Qiming Wang; Xin-Yuan Guan
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

Review 4.  Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.

Authors:  Faisal Saeed Khan; Ijaz Ali; Ume Kalsoom Afridi; Muhammad Ishtiaq; Rashid Mehmood
Journal:  Hepatol Int       Date:  2016-06-07       Impact factor: 6.047

5.  Dose- and time-dependent epigenetic changes in the livers of Fisher 344 rats exposed to furan.

Authors:  Aline de Conti; Tetyana Kobets; Claudia Escudero-Lourdes; Beverly Montgomery; Volodymyr Tryndyak; Frederick Alan Beland; Daniel R Doerge; Igor Petrovych Pogribny
Journal:  Toxicol Sci       Date:  2014-03-10       Impact factor: 4.849

6.  Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.

Authors:  Xiaoying Zhang; Cai Guo; Xiwei Wu; Arthur X Li; Limin Liu; Walter Tsark; Reinhard Dammann; Hui Shen; Steven L Vonderfecht; Gerd P Pfeifer
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

7.  Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.

Authors:  Hector Hernandez-Vargas; Marie-Pierre Lambert; Florence Le Calvez-Kelm; Géraldine Gouysse; Sandrine McKay-Chopin; Sean V Tavtigian; Jean-Yves Scoazec; Zdenko Herceg
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

8.  DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.

Authors:  Qinghua Feng; Joshua E Stern; Stephen E Hawes; Hiep Lu; Mingjun Jiang; Nancy B Kiviat
Journal:  Exp Mol Pathol       Date:  2010-01-14       Impact factor: 3.362

9.  Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang; Haiyang Li; Hui-Chen Wu; Jing Shen; Lin Wang; Ming-Whei Yu; Po-Huang Lee; I Bernard Weinstein; Regina M Santella
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

10.  Global DNA methylation in a population with aflatoxin B1 exposure.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Wei-Yann Tsai; Chien-Jen Chen; Regina M Santella
Journal:  Epigenetics       Date:  2013-07-18       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.